These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 35447273)
1. Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomography. Orban M; Dietl M; Dischl D; von Samson-Himmelstjerna P; Neubarth-Mayer J; Strüven A; Tengler A; Jakob A; Fischer M; Rizas K; Petzold T; Orban M; Braun D; Hausleiter J; Hagl C; Haas NA; Mehilli J; Pozza RD; Massberg S; Ulrich S Int J Cardiol; 2022 Jul; 358():17-24. PubMed ID: 35447273 [TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation. Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998 [TBL] [Abstract][Full Text] [Related]
3. Influence of donor age and donor-recipient age difference on intimal hyperplasia in pediatric patients with young and adult donors vs. adult patients after heart transplantation. Ulrich S; Arnold L; Michel S; Tengler A; Rosenthal L; Hausleiter J; Mueller CS; Schnabel B; Stark K; Rizas K; Grabmaier U; Mehilli J; Jakob A; Fischer M; Birnbaum J; Hagl C; Massberg S; Haas N; Pozza RD; Orban M Clin Res Cardiol; 2024 Jun; ():. PubMed ID: 38913171 [TBL] [Abstract][Full Text] [Related]
4. Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry. McGovern E; Hosking MCK; Balbacid E; Voss C; Berger F; Schubert S; Harris KC JACC Cardiovasc Imaging; 2019 Dec; 12(12):2492-2501. PubMed ID: 30031706 [TBL] [Abstract][Full Text] [Related]
5. Safety of optical coherence tomography in pediatric heart transplant patients. Ulrich SM; Lehner A; Birnbaum J; Heckel S; Haas NA; Hakami L; Schramm R; Dalla Pozza R; Fischer M; Kozlik-Feldmann R Int J Cardiol; 2017 Feb; 228():205-208. PubMed ID: 27866017 [TBL] [Abstract][Full Text] [Related]
6. Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression. Chen Z; Pazdernik M; Zhang H; Wahle A; Guo Z; Bedanova H; Kautzner J; Melenovsky V; Kovarnik T; Sonka M Med Image Anal; 2018 Dec; 50():95-105. PubMed ID: 30253306 [TBL] [Abstract][Full Text] [Related]
7. Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography. Orban M; Ulrich S; Dischl D; von Samson-Himmelstjerna P; Schramm R; Tippmann K; Hein-Rothweiler R; Strüven A; Lehner A; Braun D; Hausleiter J; Jakob A; Fischer M; Hagl C; Haas N; Massberg S; Mehilli J; Robert DP Int J Cardiol; 2021 Apr; 328():227-234. PubMed ID: 33316256 [TBL] [Abstract][Full Text] [Related]
8. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT. Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670 [TBL] [Abstract][Full Text] [Related]
9. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness. Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967 [TBL] [Abstract][Full Text] [Related]
10. Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3-D optical coherence tomography analysis. Mayerova L; Wohlfahrt P; Sonka M; Chen Z; Kautzner J; Melenovsky V; Karmazin V; Malek I; Bedanova H; Tomasek A; Ozabalova E; Krejci J; Kovarnik T; Pazdernik M Clin Transplant; 2024 Mar; 38(3):e15275. PubMed ID: 38477134 [TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography for the evaluation of asymmetric cardiac allograft vasculopathy in a child. Greenway SC; Hosking M; Harris KC Pediatr Transplant; 2014 Sep; 18(6):E190-2. PubMed ID: 24953969 [TBL] [Abstract][Full Text] [Related]
12. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation. Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884 [TBL] [Abstract][Full Text] [Related]
13. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. Cassar A; Matsuo Y; Herrmann J; Li J; Lennon RJ; Gulati R; Lerman LO; Kushwaha SS; Lerman A Eur Heart J; 2013 Sep; 34(33):2610-7. PubMed ID: 23801824 [TBL] [Abstract][Full Text] [Related]
14. Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy. Chatterjee A; Shanmugasundaram M; Lee KS; Kazui T; Rajapreyar IN; Acharya D Curr Cardiol Rep; 2024 Aug; 26(8):777-782. PubMed ID: 38864982 [TBL] [Abstract][Full Text] [Related]
16. Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis. Pazdernik M; Wichterle D; Chen Z; Bedanova H; Kautzner J; Melenovsky V; Karmazin V; Malek I; Stiavnicky P; Tomasek A; Ozabalova E; Krejci J; Wahle A; Zhang H; Kovarnik T; Sonka M Clin Transplant; 2020 Feb; 34(2):e13773. PubMed ID: 31859379 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Fibrotic Plaques in Angiographic Manifest Cardiac Allograft Vasculopathy in Long-term Heart Transplanted Patients Using Optical Coherence Tomography. Orban M; Dischl D; Müller C; Ulrich S; Petzold T; Rizas K; Orban MW; Braun D; Hausleiter J; Hagl C; Mehilli J; Massberg S Transplant Direct; 2022 Jan; 8(1):e1266. PubMed ID: 34966839 [TBL] [Abstract][Full Text] [Related]
18. Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis. Park KH; Kwon TG; Matsuzawa Y; Sun T; Liu Z; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):272-9. PubMed ID: 26657475 [TBL] [Abstract][Full Text] [Related]
19. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities. Javaheri A; Saha N; Lilly SM Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390 [TBL] [Abstract][Full Text] [Related]
20. Fibrotic plaques in heart transplanted patients and their association with insulin resistance syndrome and Lp(a). Orban M; Kuehl A; Dischl D; Müller C; Ulrich S; Petzold T; Rizas KD; Orban M; Braun D; Hausleiter J; Hagl C; Mehilli J; Massberg S Int J Cardiol; 2022 Sep; 363():218-224. PubMed ID: 35772579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]